Lisata Therapeutics Inc (LSTA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Lisata Therapeutics Inc-Aktie (LSTA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.07	-	1.00	-	-
Operating Expenses	15.55% 4.938	5.847	5.949	5.336	5.523
Benefits Costs and Expenses	16.83% 4.729	5.686	-	-	-
Costs And Expenses	16.83% 4.729	5.686	-	-	-
Depreciation and Amortization	2.33% 0.044	0.043	0.041	0.042	0.045
Operating Income/Loss	16.74% -4.868	-5.847	-4.949	-5.336	-5.523
Nonoperating Income/Loss	29.81% 0.209	0.161	0.339	0.406	0.479
Income/Loss From Equity Method Investments	-	-	-	-0.03	-
Income/Loss From Continuing Operations Before Tax	18.06% -4.659	-5.686	-4.61	-4.93	-5.044
Income Tax Expense/Benefit	100.00% -	-0.962	-	-	-
Income/Loss From Continuing Operations After Tax	1.38% -4.659	-4.724	-4.61	-4.93	-5.044
Net Income/Loss	1.38% -4.659	-4.724	-4.61	-4.93	-5.044
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.03% 8.605	8.602	0.022	8.321	8.308
Diluted Average Shares	0.03% 8.605	8.602	0.022	8.321	8.308
Basic Earnings Per Share	1.82% -0.54	-0.55	-0.55	-0.59	-0.61
Diluted Earnings Per Share	1.82% -0.54	-0.55	-0.55	-0.59	-0.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$24.54

0.95%

INCY

$84.00

0.90%

SMMT

$26.98

2.70%

BNTX

$104.79

0.27%

INSM

$132.17

3.00%

ONC

$308.91

0.09%